USPH · U.S. Physical Therapy, Inc.
$74.58
+3.08% last session
End-of-day data · updated 2026-07-28
Market cap
$1B
Enterprise value
$2B
Trailing P/E
153.3
Forward P/E
22.5
Dividend yield
2.0%
Beta
1.14
Avg volume
0M
Employees
5K
2D change
—
5D change
5.03%
10D change
4.19%
30D change
11.43%
60D change
19.27%
MTD change
7.47%
YTD change
-0.55%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — USPH
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-06-24
Latest call per bank · past 12 months
JP Morgan
Overweight$100
+34.1% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-06-24 | Citizens | Reiterates | Market Outperform | $98.00 |
| 2026-05-13 | Barrington Research | Maintains | Outperform | $103 → $90.00 |
| 2026-05-08 | Citizens | Maintains | Market Outperform | $113 → $98.00 |
| 2026-02-20 | Barrington Research | Maintains | Outperform | $103 |
| 2026-01-05 | Barrington Research | Maintains | Outperform | $103 |
| 2025-11-24 | JP Morgan | Maintains | Overweight | $110 → $100 |
| 2025-10-24 | Barrington Research | Maintains | Outperform | $103 |
| 2025-08-08 | Barrington Research | Maintains | Outperform | $98.00 → $103 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 69 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 17.4% above the 50-day MA ($67.27).
- Price vs 200-day MA: Trading 4.5% above the 200-day MA ($75.62).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is positive (+0.36) — short-term momentum is improving.
- 52-week range: Price sits between the 52-week low ($58.57) and high ($91.35).
USPH Price Chart
Loading chart for USPH…
Fundamentals
About U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$86B -16.3% YTD
THC
Tenet Healthcare Corporation
$21B 22.5% YTD
DVA
DaVita Inc.
$15B 108.0% YTD
FMS
Fresenius Medical Care AG
$13B 8.6% YTD
EHC
Encompass Health Corporation
$11B 7.9% YTD
UHS
Universal Health Services, Inc.
$10B -26.8% YTD
ENSG
The Ensign Group, Inc.
$10B 2.3% YTD
CHE
Chemed Corp
$7B 19.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.